(Preconference Session) AMCP Talks: Incorporating Value Framework Assessments in Coverage and Reimbursement Decisions

Please Note: This session is open to AMCP 2023 meeting registrants. No pre-registration is required.
This session is not accredited for continuing pharmacy education.

Value frameworks and assessments are increasingly used as a resource for evaluating the value of pharmaceuticals and other health technologies in coverage and negotiation processes. These frameworks are designed to help health care decision-makers determine the comparative effectiveness and value of a medication or intervention. These frameworks continue to evolve and are designed for different decision-making applications and target audiences.

According to a recent survey of payers, the most important factors when selecting a framework to inform decision-making are the metrics and outcomes, comparative clinical effectiveness information, methodologic rigor, and transparency. Although payers agree on these important factors, their decision-making processes and incorporation of value assessment information in these decisions can differ vastly. This session aims to explore:
• payer decision-making processes and structures,
• current sources and use of value assessments in these decisions,
• future value assessment information needs, and
• the potential impact of the Inflation Reduction Act.

Join us to hear, from various payer perspectives, real-world strategies for incorporating and assessing value in their coverage and reimbursement decision-making. You won’t want to miss this session!